| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 61.38B | 60.68B | 57.79B | 55.03B | 48.06B | 47.10B |
| Gross Profit | 19.74B | 19.44B | 19.17B | 17.54B | 14.97B | 15.06B |
| EBITDA | 4.02B | 4.16B | 4.61B | 3.48B | 1.18B | 570.00M |
| Net Income | 2.24B | 2.09B | 2.37B | 1.54B | 87.00M | -331.00M |
Balance Sheet | ||||||
| Total Assets | 42.59B | 41.84B | 43.41B | 40.02B | 37.82B | 38.53B |
| Cash, Cash Equivalents and Short-Term Investments | 8.12B | 8.09B | 9.68B | 7.14B | 6.04B | 7.63B |
| Total Debt | 1.12B | 540.00M | 424.00M | 425.00M | 481.00M | 614.00M |
| Total Liabilities | 7.58B | 6.66B | 8.65B | 7.34B | 6.19B | 6.30B |
| Stockholders Equity | 34.94B | 35.11B | 34.69B | 32.62B | 31.57B | 32.17B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 284.00M | 3.34B | 639.00M | -696.00M | 472.00M |
| Operating Cash Flow | 0.00 | 923.00M | 4.70B | 2.33B | 430.00M | 1.10B |
| Investing Cash Flow | 0.00 | -864.00M | -1.48B | -378.00M | -1.38B | -407.00M |
| Financing Cash Flow | 0.00 | -1.69B | -678.00M | -686.00M | -647.00M | -404.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥477.47B | 10.13 | 6.90% | 2.71% | -0.06% | 137.47% | |
78 Outperform | ¥32.13B | 6.41 | ― | 4.00% | 5.42% | 15.41% | |
77 Outperform | ¥107.56B | 7.99 | 7.53% | 3.01% | 5.44% | 45.99% | |
74 Outperform | ¥81.02B | 12.05 | ― | 6.64% | 2.85% | -9.13% | |
73 Outperform | ¥59.39B | 5.78 | ― | 3.31% | 0.83% | -9.16% | |
70 Outperform | ¥150.84B | 4.25 | 10.46% | 2.35% | 4.56% | 49.23% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |